Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Role of Meprins on the Brain Extracellular Matrix and Perineuronal Nets.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Same author

Integrating psychological care into atrial fibrillation management: insights from HOPE-AF.

European journal of cardiovascular nursing·2026

Same author

Meprin-β levels are increased in the brain and the cerebrospinal fluid of Alzheimer's disease patients.

Alzheimer's research & therapy·2026

Same author

Comparative Analysis of Circulating Cytokines and Adrenergic Autoantibodies in Postural Orthostatic Tachycardia Syndrome, Postacute Sequelae of SARS-CoV-2, and Healthy Controls.

Journal of the American Heart Association·2026

Same author

Transport pathways across the blood-brain barrier for waste clearance and drug delivery.

Fluids and barriers of the CNS·2026

Same author

Proton Transfer Charge Reduction Enables Isobaric Labeling-Based Proteoform Quantification of Overlapping Signals in Top-Down Mass Spectrometry.

Journal of the American Society for Mass Spectrometry·2026

Search research articles

Related Experiment Video

Updated: Jan 8, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Meprin β elevates hippocampal soluble Aβ in the APP/V717I mouse model.

Maximilian Keller¹, Celine Gallagher², Liana Marengo¹

¹Molecular Neurodegeneration, Institute for Pathobiochemistry, University Medical Center Mainz, Mainz, Germany.

Experimental Neurology

|December 21, 2025

Summary

Alzheimer's disease research identified meprin beta as a key enzyme in generating amyloid-beta (Aβ) peptides. Overexpressing meprin beta in mice increased Aβ levels, especially in the hippocampus, offering a new model for Alzheimer's disease studies.

Keywords:

Alzheimers disease Amyloid β Electrophysiology Meprin β Proteomics

More Related Videos

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

Related Experiment Videos

Last Updated: Jan 8, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

Area of Science:

Neuroscience
Biochemistry
Genetics

Background:

Alzheimer's disease (AD) pathology involves amyloid-beta (Aβ) peptides, crucial for both familial and sporadic forms.
Understanding Aβ generation is vital, with BACE1 traditionally studied, but it doesn't produce N-terminally truncated Aβ species prevalent in AD brains.
Alternative proteases, like meprin β, are increasingly recognized for their role in APP processing and AD pathology.

Purpose of the Study:

To develop a more accurate mouse model for Alzheimer's disease (AD) pathology beyond BACE1-overexpressing models.
To investigate the role of meprin β in Amyloid Precursor Protein (APP) cleavage within the hippocampus and cerebral cortex.
To assess the impact of meprin β overexpression on Aβ generation and potential behavioral deficits.

Main Methods:

Development of a mouse model overexpressing meprin β.
Biochemical analysis of soluble Aβ levels in hippocampal and cerebral cortex tissues.
Assessment of behavioral deficits in the engineered mouse model.

Main Results:

Overexpression of meprin β significantly increased soluble Aβ levels, with a pronounced effect in the hippocampus.
Meprin β activity appears higher or the hippocampus shows greater vulnerability compared to the cerebral cortex.
No observable behavioral deficits were detected in mice overexpressing meprin β, despite biochemical changes.

Conclusions:

Meprin β plays a significant role in generating Aβ species relevant to Alzheimer's disease (AD) pathology.
The hippocampus may be particularly susceptible to meprin β-mediated Aβ production.
This study provides a novel mouse model for AD research, highlighting a region-specific role for meprin β that warrants further investigation beyond immediate behavioral impairment.